Elicio Therapeutics Inc. (ELTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.46M
Last updated: Nov 17, 2026 at 4:29 PM ET
Elicio Therapeutics Inc. (ELTX) Stock Chart
Elicio Therapeutics (ELTX) has a latest price of $1.43 on Nov 17, 2026, 91.1% below its 52-week high of $16.00. Its price fell 84.0% over the past 12 months. The month-end price fell 96.0% over the 5 years through Oct 2026, a compound annual decline of 47.4%.
Price Chart
From Feb 2021 to Oct 2026, its highest month-end close was $180.70 in Mar 2021 and its lowest $1.68 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ELTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ELTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 54.3%, and over 6 months it fell 84.4%. The month-end price fell 75.0% over the 3 years through Oct 2026, a compound annual decline of 37.0%.
| Period | Change |
|---|---|
| 1 month | -7.7% |
| 3 months | -54.3% |
| 6 months | -84.4% |
| 12 months | -84.0% |
| 12 months, with dividends | -84.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -75.0% | -37.0% |
| 5 years | -96.0% | -47.4% |
Price by Year
Its best calendar year was 2025, when the price rose 56.1%, and its weakest was 2022, when it fell 72.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.68 | -78.9% |
| 2025 | $7.96 | +56.1% |
| 2024 | $5.10 | -38.8% |
| 2023 | $8.34 | +2.8% |
| 2022 | $8.12 | -72.0% |
Trading Range
The price is 19.3% below its 50-day average of $1.77 and 77.6% below its 200-day average of $6.39.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.43 | |
| 52-week high | $16.00 | -91.1% |
| 52-week low | $1.25 | +14.4% |
| 50-day average | $1.77 | -19.3% |
| 200-day average | $6.39 | -77.6% |
Price Risk
Over 3 years, its largest fall from a peak was 90.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.32 |
| Largest fall, 1 year | -90.6% |
| Largest fall, 3 years | -90.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ELTX
What is ELTX's 1-year price change?
Elicio Therapeutics's price fell 84.0% over the past 12 months. With dividends included, the 12-month total return was -84.0%.
What is ELTX's 5-year price change?
Elicio Therapeutics's month-end price fell 96.0% over the 5 years through Oct 2026, a compound annual decline of 47.4%. These figures leave out dividends.
What is ELTX's 52-week high and low?
Elicio Therapeutics's 52-week high is $16.00 and its 52-week low is $1.25. Its latest price of $1.43 on Nov 17, 2026 is 91.1% below the high.
What is ELTX's beta?
Elicio Therapeutics's 1-year beta against the S&P 500 is 0.32, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 90.6%.
Is the ELTX chart free?
Yes. Advanced Charting for ELTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ELTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors